International Stem Cell Corporation reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 0.034 million compared to USD 0.009 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0995 USD | +62.58% | +39.75% | +60.48% |
1st Jan change | Capi. | |
---|---|---|
+60.48% | 796K | |
+0.67% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+6.55% | 24.63B | |
-21.66% | 18.2B | |
+29.96% | 12.01B | |
-1.57% | 11.76B | |
+16.03% | 10.4B | |
-4.80% | 9.94B |
- Stock Market
- Equities
- ISCO Stock
- News International Stem Cell Corporation
- International Stem Cell Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023